Dr Anusha Kalbasi | Assistant Professor, Chief, Sarcoma Radiation Oncology Service
U.C.L.A. Jonsson Comprehensive Cancer Center

Dr Anusha Kalbasi, Assistant Professor, Chief, Sarcoma Radiation Oncology Service, U.C.L.A. Jonsson Comprehensive Cancer Center

Dr. Anusha Kalbasi is a radiation oncologist and translational scientist in the UCLA Department of Radiation Oncology and Jonsson Comprehensive Cancer Center. He is the Chief Radiation Oncologist of the UCLA Sarcoma Program, one of the largest Sarcoma programs in the United States. As part of Dr. Antoni Ribas’ lab in the Parker Institute for Cancer Immunotherapy, his research is focused on immunotherapeutic strategies for the treatment of solid malignancies, including leveraging genomic and transcriptomic databases to understand immune resistance and identify novel immunotherapeutic targets. Dr. Kalbasi earned his undergraduate and medial degrees at UCLA and the David Geffen School of Medicine at UCLA. He completed an HHMI-NIH research fellowship at the National Cancer Institute’s Surgery Branch under mentorship from Dr. Steven Rosenberg, where he studied genetically engineering T cells for the treatment of solid tumors. Dr. Kalbasi completed his clinical training in radiation oncology at the University of Pennsylvania, where he studied macrophage biology and pancreatic cancer immunotherapy under mentorship from Dr. Gregory Beatty. He has been funded through early career awards through the Conquer Cancer Foundation of ASCO, the Radiological Society of North America, and the Tower Research Foundation.

Appearances:



Agenda Day 2 @ 08:40

Precision oncology needs data sharing: Integrating genomic and clinical data to advance patient care and understanding patient outcomes

  • Does decoding the genes of patients’ cancer help to accelerate the pace of discovery?
  • Is more sequencing, across large populations worthwhile?
  • How to combine all these data into one searchable pool?
  • How will this translate to better and more personalized vaccines or treatments for patients?
  • The paradigm of bringing multiple cancer centers together, connecting academics with industry and how to data share
  • The type of data sharing necessary to learn from the experience of patients that go through cancer immunotherapy

back to speakers